RESUMO
Mucositis is the most common side effect due to chemotherapy or radiotherapy. It refers to the inflammation of intestinal mucous membranes, and it is associated with complications such as diarrhea, weight loss, and increased intestinal permeability (IP). This study was designed to evaluate the effect of diet containing conjugated linoleic acid (CLA)-enriched butter on intestinal damage and inflammatory response after 24 h of 5-fluorouracil (5-FU)-induced mucositis. Mice were divided into four groups: CTL; CLA; 5-FU, and CLA 5-FU, and they were fed for 31 days. On the 30th experimental day, mucositis was induced by unique injection of 300 mg/kg of 5-FU. After 24 h (31st experimental day), IP was evaluated; ileum and fecal material were collected to determine cytokine level and myeloperoxidase (MPO) activity and secretory immunoglobulin A (sIgA). The 5-FU group showed an increase in IP and MPO activity (CTL vs. 5-FU: P < 0.05). Additionally, increased levels of IP and MPO were observed in CLA 5-FU group compared to those in the test groups (P < 0.05). Animals in the CLA 5-FU group showed reduced concentrations of sIgA (CTL vs. CLA 5-FU: P < 0.05). CLA-enriched butter exacerbating the 5-FU-induced intestinal damage. Safety concerns regarding the use of CLA require further investigation.
Assuntos
Manteiga , Mucosa Intestinal/patologia , Ácidos Linoleicos Conjugados/farmacologia , Mucosite/dietoterapia , Animais , Peso Corporal , Quimiocinas/metabolismo , Citocinas/metabolismo , Fluoruracila/efeitos adversos , Alimentos Fortificados , Imunoglobulina A/metabolismo , Mucosa Intestinal/efeitos dos fármacos , Intestinos/fisiopatologia , Masculino , Camundongos Endogâmicos BALB C , Mucosite/induzido quimicamente , Permeabilidade , Peroxidase/metabolismoRESUMO
Mucositis is defined as inflammatory and ulcerative lesions along of the gastrointestinal tract that leads to the imbalance of the intestinal microbiota. The use of compounds with action on the integrity of the intestinal epithelium and their microbiota may be a beneficial alternative for the prevention and/or treatment of mucositis. So, the aim of this study was to evaluate the effectiveness of the association of fructo-oligosaccharides (FOS) and arginine on intestinal damage in experimental mucositis. BALB/c mice were randomized into five groups: CTL (without mucositis + saline), MUC (mucositis + saline), MUC + FOS (mucositis + supplementation with FOS-1st until 10th day), MUC + ARG (mucositis + supplementation with arginine-1st until 10th day), and MUC + FOS + ARG (mucositis + supplementation with FOS and arginine-1st until 10th day). On the 7th day, mucositis was induced with an intraperitoneal injection of 300 mg/kg 5-fluorouracil (5-FU), and after 72 h, the animals were euthanized. The results showed that association of FOS and arginine reduced weight loss and oxidative stress (P < 0.05) and maintained intestinal permeability and histological score at physiological levels. The supplementation with FOS and arginine also increased the number of goblet cells, collagen area, and GPR41 and GPR43 gene expression (P < 0.05). Besides these, the association of FOS and arginine modulated intestinal microbiota, leading to an increase in the abundance of the genera Bacteroides, Anaerostipes, and Lactobacillus (P < 0.05) in relation to increased concentration of propionate and acetate. In conclusion, the present results show that the association of FOS and arginine could be important adjuvants in the prevention of intestinal mucositis probably due to modulated intestinal microbiota.
Assuntos
Microbioma Gastrointestinal , Mucosite , Camundongos , Animais , Mucosite/tratamento farmacológico , Mucosite/metabolismo , Mucosite/patologia , Arginina/metabolismo , Intestinos , Mucosa Intestinal/metabolismo , Fluoruracila , Oligossacarídeos/farmacologiaRESUMO
Inflammatory bowel diseases, irritable bowel syndrome, and mucositis are characterized by intestinal inflammation, but vary according to their pathological mechanisms, severity, location, and etiology. Significant intestinal inflammation that occurs in these diseases induces weight loss, nutritional depletion, and gastrointestinal tract dysfunction. Nutritional support is important in alleviating symptoms and improving patients' quality of life. In this review, we summarize some nutritional components used to manage intestinal disorders. These include fatty acids, probiotics, parabiotics, postbiotics, prebiotics, synbiotics, and low FODMAP (LFD) diets. These components and LFD diets have been studied and clinical trials have been designed to develop new strategies to alleviate intestinal inflammation and improve the quality of life. Clinical trials on their use in intestinal inflammation do not allow firm conclusions to be drawn mainly because of the heterogeneity of the dose used and the study design or their inconclusive results. However, in the majority of cases, the use of omega-3, probiotics, parabiotics, postbiotics, prebiotics, synbiotics, and LFD improve the health.
Assuntos
Suplementos Nutricionais , Inflamação/terapia , Enteropatias/terapia , Animais , Humanos , Inflamação/fisiopatologia , Doenças Inflamatórias Intestinais/fisiopatologia , Doenças Inflamatórias Intestinais/terapia , Enteropatias/fisiopatologia , Síndrome do Intestino Irritável/fisiopatologia , Síndrome do Intestino Irritável/terapia , Mucosite/fisiopatologia , Mucosite/terapia , Apoio Nutricional/métodos , Qualidade de VidaRESUMO
High-fat diets seem to have a negative influence on the development of obesity and the processes associated with low-grade chronic systemic inflammation. In recent years, partial hydrogenated oil, rich in trans isomers, has been associated with deleterious health effects. It has been replaced by interesterified fat (IF). However, there is no evidence whether IF ingestion can exert adverse effects on the intestinal mucosa. Thus, this study aimed to evaluate the effect of IF on the intestinal mucosa of male Swiss mice fed a normal or high-fat diet, focusing on its effects on intestinal permeability and bacterial translocation and its possible damage to the intestinal epithelium. The animals were divided into 4 groups: Control (C) and Interesterified Control (IC) groups (10 En% lipids from unmodified fat or interesterified fat, respectively) and High Fat (HF) and Interesterified High Fat (IHF) groups (45 En% lipids from unmodified fat or interesterified fat, respectively). Compare to C, the IC, HF, and IHF groups presented flattened epithelium, a shorter villi length and a lower percentage of goblet cells, less mucin 2, an increased oxidative stress and more inflammatory cells, higher IL-1ß, IL-17, and IL-23 levels. These groups also presented increased intestinal permeability and gene expression of the protein claudin 2, while JAM-A and claudin 1 gene expression was reduced. IC and IHF increased IL-6 levels while reducing occludin expression. In addition, the IC group also presented a mucosa with lesions of low intensity in the ileum, an increased mucin 5ac, TNF-α levels, and reduced occludin expression in the distal jejunum. Moreover, there was a significant increase in bacterial translocation in the IC group to blood, liver, and lungs, while HF and IHF groups presented bacterial translocation which was restricted to the mesenteric lymph nodes. In summary, our results supported the hypothesis that IF added to a normolipidic diet can be considered harmful or even worse when compared to a HF.
Assuntos
Translocação Bacteriana , Ácidos Graxos , Animais , Dieta Hiperlipídica/efeitos adversos , Expressão Gênica , Masculino , Camundongos , Óleo de Palmeira , Permeabilidade , Proteínas de Junções Íntimas/genéticaRESUMO
Intestinal mucositis (IM) is a frequent adverse effect in anticancer therapy without standard treatment. The oil obtained from sucupira (Pterodon emarginatus) has anti-inflammatory properties, and the soybean lecithin reduces the intestinal toxicity of several xenobiotics. However, their water insolubility impairs the in vivo application. For this reason, we evaluated if the nanoencapsulation of sucupira oil (SO) in lecithin-based nanocapsules (SO-NC) could be a therapeutically effective system for the treatment of IM in murine cisplatin (CDDP)-induced intestinal mucositis model. SO was analyzed by LC-HRMS/MS and HPLC. SO-NC was prepared by nanoprecipitation and characterized using DLS, HPLC, and AFM. Mice body weight and food consumption were assessed daily during experimental mucositis induced by CDDP. The animals were euthanized, and intestinal permeability, inï¬ammatory mediators, and intestinal histology were performed. SO-NC demonstrated adequate characteristics for oral administration as size under 300 nm, IP < 0.3, high EE, and spherical shape. In vitro cytotoxicity performed against RAW 264.7 cell lines resulted in cell viability above 80 % confirming the non-cytotoxic profile of SO (IC50 268 µg/mL) and SO-NC (IC50 118.5 µg/mL) up to 117.2 µg/mL. The untreated mice showed intestinal toxicity after i.p. of CDDP, principally weight loss, increased intestinal permeability, and MPO and TNF-α levels. Surprisingly, the administration of SO to CDDP-mucositis animals did not circumvent the CDDP effects and increased intestinal permeability. However, SO-NC proved efficient in mitigating the experimental intestinal mucositis by improving intestinal epithelium architecture, reducing intestinal permeability, and improving the MPO levels. In conclusion, SO-NC can positively impact intestinal mucositis by promoting mucosal recovery. This is a promising strategy for developing a new treatment for intestinal mucositis.
RESUMO
Intestinal ischemia is a vascular emergency that arises when blood flow to the intestine is compromised. Reperfusion is necessary to restore intestinal function but might lead to local and systemic inflammatory responses and bacterial translocation, with consequent multiple organ dysfunction syndrome (MODS). During reperfusion occurs production of reactive oxygen species. These species contribute to intestinal injury through direct toxicity or activation of inflammatory pathways. Fullerol is a nanacomposite which has been shown to act as reactive oxygen species and reactive nitrogen species (RNS) scavengers. Thus, our aim was to evaluate whether Fullerol confer anti-inflammatory activity during intestinal ischemia and reperfusion (IIR). Intestinal ischemia was induced by total occlusion of the superior mesenteric artery. Groups were treated with vehicle or Fullerol 10 min before reperfusion. Mice were euthanized after 6 h of reperfusion, and small intestines were collected for evaluation of plasma extravasation, leukocyte influx, cytokine production and histological damage. Bacterial translocation to the peritoneal cavity and reactive oxygen and nitrogen species production by lamina propria cells were also evaluated. Our results showed that treatment with Fullerol inhibited bacterial translocation to the peritoneal cavity, delayed and decreased the lethality rates and diminished neutrophil influx and intestinal injury induced by IIR. Reduced severity of reperfusion injury in Fullerol-treated mice was associated with blunted reactive oxygen and nitrogen species production in leukocytes isolated from gut lamina propria and decreased production of pro-inflammatory mediators. Thus, the present study shows that Fullerol is a potential therapy to treat inflammatory bowel disorders associated with bacterial translocation, such as IIR.
Assuntos
Anti-Inflamatórios/farmacologia , Antioxidantes/farmacologia , Fulerenos/farmacologia , Intestinos/irrigação sanguínea , Intestinos/efeitos dos fármacos , Isquemia Mesentérica/tratamento farmacológico , Nanocompostos , Traumatismo por Reperfusão/prevenção & controle , Animais , Translocação Bacteriana/efeitos dos fármacos , Citocinas/metabolismo , Modelos Animais de Doenças , Mediadores da Inflamação/metabolismo , Intestinos/microbiologia , Intestinos/patologia , Masculino , Isquemia Mesentérica/metabolismo , Isquemia Mesentérica/microbiologia , Isquemia Mesentérica/patologia , Camundongos Endogâmicos C57BL , Infiltração de Neutrófilos/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Permeabilidade , Espécies Reativas de Nitrogênio/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Traumatismo por Reperfusão/metabolismo , Traumatismo por Reperfusão/microbiologia , Traumatismo por Reperfusão/patologia , Índice de Gravidade de DoençaRESUMO
The beneficial effects of prebiotic, such as fructo-oligosaccharides (FOS), in intestinal inflammation have been demonstrated in several studies. Herein, we evaluate whether joint treatment with FOS, both before and during mucositis, had additional beneficial effects and investigated the mechanisms underlying in the action of FOS on the intestinal barrier. BALB/c mice were randomly divided into five groups: CTR (without mucositisâ¯+â¯saline solution), FOS (without mucositisâ¯+â¯6 % FOS), MUC (mucositisâ¯+â¯saline solution), PT (mucositisâ¯+â¯6 % FOS supplementation before disease induction), and TT (mucositisâ¯+â¯6 % FOS supplementation before and during disease induction). Mucositis was induced by intraperitoneal injection (300â¯mg/kg) of 5-fluorouracil (5-FU). After 72â¯h, the animals were euthanized and intestinal permeability (IP), tight junction, bacterial translocation (BT), histology and morphometry, and immunoglobulin A secretory (sIgA), inflammatory infiltrate, and production of short-chain fatty acids (acetate, butyrate and propionate) were evaluated. The MUC group showed an increase in the IP, BT, and inflammatory infiltrate but a decrease in the tight junction expression and butyrate and propionate levels (Pâ¯<â¯0.05). In the PT and TT groups, FOS supplementation maintained the IP, tight junction expression, and propionate concentration within physiologic levels, increased butyrate levels, and reduced BT and inflammatory infiltrate (Pâ¯<â¯0.05). Total treatment with FOS (TT group) was more effective in maintaining histological score, morphometric parameters, and sIgA production. Thus, total treatment (prophylactic and therapeutic supplementation) with FOS was more effective than pretreatment alone, in reducing 5-FU-induced damage to the intestinal barrier.
Assuntos
Bactérias/efeitos dos fármacos , Ácidos Graxos Voláteis/metabolismo , Microbioma Gastrointestinal/efeitos dos fármacos , Íleo/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Mucosite/induzido quimicamente , Oligossacarídeos/farmacologia , Prebióticos , Junções Íntimas/efeitos dos fármacos , Acetatos/metabolismo , Animais , Bactérias/metabolismo , Translocação Bacteriana/efeitos dos fármacos , Butiratos/metabolismo , Modelos Animais de Doenças , Fluoruracila , Íleo/metabolismo , Íleo/microbiologia , Íleo/patologia , Imunoglobulina A Secretora/metabolismo , Mediadores da Inflamação/metabolismo , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiologia , Mucosa Intestinal/patologia , Masculino , Camundongos Endogâmicos BALB C , Mucosite/metabolismo , Mucosite/microbiologia , Mucosite/patologia , Permeabilidade , Propionatos/metabolismo , Junções Íntimas/metabolismo , Junções Íntimas/microbiologia , Junções Íntimas/patologiaRESUMO
BACKGROUND: Imbalances in a variety of factors, including genetics, intestinal flora, and mucosal immunity, can contribute to the development of ulcerative colitis and its side effects. This study evaluated the effects of pretreatment or treatment with arginine by oral administration on intestinal permeability, bacterial translocation (BT), and mucosal intestinal damage due to colitis. METHODS: C57BL/6 mice were distributed into 4 groups: standard diet and water (C: control group), standard diet and dextran sodium sulfate (DSS) solution (Col: colitis group), 2% L-arginine supplementation for 7 days prior to DSS administration and during disease induction (PT: pretreated group), and 2% L-arginine supplementation during disease induction (T: treated group). Colitis was induced by administration of 1.5% DSS for 7 days. After 14 days, intestinal permeability and BT were evaluated; colons were collected for histologic analysis and determination of cytokines; feces were collected for measurement of immunoglobulin A (IgA). RESULTS: The Col group showed increased intestinal permeability (C vs Col: P < .05) and BT (C vs Col: P < .05). In the arginine-supplemented groups (PT and T), this amino acid tended to decrease intestinal permeability. Arginine decreased BT to liver during PT (P < .05) and to blood, liver, spleen, and lung during T (P < .05). Histologic analysis showed that arginine preserved the intestinal mucosa and tended to decreased inflammation. CONCLUSIONS: Arginine attenuates weight loss and BT in mice with colitis.
Assuntos
Arginina/farmacologia , Translocação Bacteriana/efeitos dos fármacos , Colite/tratamento farmacológico , Redução de Peso/efeitos dos fármacos , Administração Oral , Animais , Colite/induzido quimicamente , Sulfato de Dextrana , Fezes/química , Feminino , Imunoglobulina A/análise , Absorção Intestinal/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/metabolismo , Intestinos/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , PermeabilidadeRESUMO
The intestinal epithelium is composed of specialized epithelial cells that form a physical and biochemical barrier to commensal and pathogenic microorganisms. However, dysregulation of the epithelial barrier function can lead to increased intestinal permeability and bacterial translocation across the intestinal mucosa, which contributes to local and systemic immune activation. The increase in these parameters is associated with inflammatory bowel disease, physical exercise under heat stress, intestinal obstruction, ischemia, and mucositis, among other conditions. Lately, there has been growing interest in immunomodulatory nutrients and probiotics that can regulate host immune and inflammatory responses and possibly restore the intestinal barrier. Immunomodulators such as amino acids (glutamine, arginine, tryptophan, and citrulline), fatty acids (short-chain and omega-3 fatty acids and conjugated linoleic acids), and probiotics (Bifidobacterium, Saccharomyces, and Lactobacillus) have been reported in the literature. Here, we review the critical roles of immunomodulatory nutrients in supporting gut barrier integrity and function.
Assuntos
Homeostase , Fatores Imunológicos/farmacologia , Mucosa Intestinal/efeitos dos fármacos , Animais , Arginina/farmacologia , Bifidobacterium , Citrulina/farmacologia , Modelos Animais de Doenças , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Células Epiteliais/microbiologia , Ácidos Graxos Ômega-3/farmacologia , Glutamina/farmacologia , Humanos , Doenças Inflamatórias Intestinais/microbiologia , Doenças Inflamatórias Intestinais/terapia , Mucosa Intestinal/citologia , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiologia , Lactobacillus , Ácidos Linoleicos Conjugados/farmacologia , Permeabilidade , Probióticos , Saccharomyces , Triptofano/farmacologiaRESUMO
The purpose of this study was to evaluate the nutritional status of preschool-aged children before and after intervention with nutritional education. The research was carried out with 101 preschoolers in six daycare centers in Viçosa, State of Minas Gerais, between March and December, 2009. Anthropometric (weight and height) and dietetic evaluations (direct weighing and food intake record) were performed before and after six months of the nutritional intervention program. It was possible to observe that the height (z-score) was significantly improved after the intervention. The weight (z-score) was not significantly altered, as well as the intake of protein, carbohydrates, lipids, vitamin A, vitamin C, calcium and zinc. There was a significant reduction in iron consumption. Low bioavailability was observed in the diet and iron intake inadequacy was noted in 100% of the children studied. There was significant improvement in the consumption of fruits after the nutritional intervention. The diet of all the children was classified as "requires changes", either before or after the nutritional intervention program. A long-term nutritional education program is necessary to promote healthy eating habits and ensure food and nutritional safety among preschool-aged children.
El objetivo de este estudio fue evaluar el perfil nutricional de preescolares antes y después de una intervención de educación nutricional. El estudio fue realizado con 101 preescolares de seis jardines maternales municipales de Viçosa, MG, Brasil, entre marzo y diciembre de 2009. Los niños fueron sometidos a evaluaciones de antropometría (peso y estatura) y de dieta (pesaje directo de alimentos y registro alimentario), antes y después de seis meses de intervención nutricional. Se observó que la estatura (grado z) fue significantemente mayor tras la intervención; en cambio, no hubo diferencias significativas en el peso (grado z). La ingesta de proteínas, hidratos de carbono, lípidos, vitamina A, vitamina C, calcio y zinc no presentaron diferencia significativa, sin embargo la ingesta de hierro fue menor. El promedio de disponibilidad de azúcar y la prevalencia de inadecuación de la ingesta de aceite se redujeron. Se observó que la dieta fue de baja biodisponibilidad y que 100% de los niños no tenían una adecuada ingesta de hierro. Hubo una mejora significativa de la ingesta de frutas. Las dietas de todos los niños fueron clasificados como "necesita de cambios" tanto antes como después de la intervención nutricional. Por lo tanto, se verificó la importancia de la continuidad de las actividades de educación nutricional, con el objetivo de promover hábitos alimentarios saludables en los preescolares.
O objetivo do estudo foi avaliar o perfil nutricional de pré-escolares antes e após intervenção com educação nutricional. O estudo foi realizado com 101 pré-escolares de seis creches municipais em Viçosa, MG, no período de março a dezembro de 2009. As crianças foram submetidas a avaliações antropométricas (peso e estatura) e dietéticas (pesagem direta de alimentos e registro alimentar), antes e após seis meses de intervenção nutricional. Observou-se que a estatura (escore z) foi significantemente superior após a intervenção, já o peso (escore z) não apresentou diferença significativa. A ingestão de proteínas, carboidratos, lipídios, vitamina A, vitamina C, cálcio e zinco não apresentou diferença significativa, enquanto a de ferro reduziu. A média da disponibilidade de açúcar e a prevalência de inadequação de óleo reduziram. Verificou-se que a dieta é de baixa biodisponibilidade e que 100% das crianças apresentaram consumo inadequado de ferro. Houve melhora significativa no consumo de frutas. As dietas de todas as crianças foram classificadas como "necessita de modificações" tanto antes quanto após a intervenção nutricional. Diante disso, verificou-se a importância da continuidade das atividades de educação nutricional, com o intuito de promover a formação de hábitos alimentares saudáveis nos pré-escolares.